Motivational Interview and Nomophobia

July 9, 2025 updated by: Sultan Ayaz Alkaya

The Effect of Motivational Interviewing on the Level of Nomophobia and Smartphone Addiction of Nursing Students

A preparation session and a motivational interview consisting of 4 sessions will be applied to nursing students. Data collection tools will be applied before, after and at 3 months.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06490
        • Gazi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • being over 18 years of age
  • being a first-year nursing student
  • agreeing to participate in the research

Exclusion Criteria:

  • having problems understanding and speaking Turkish
  • having visual or hearing impairment
  • having a neuropsychiatric disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Motivational Interview
Preparation and motivational interviewing practice consisting of 4 sessions
After the preparation session, 4 sessions of motivational interviewing will be applied. Motivational interviewing techniques will be used in the interviews to target behavioral change.
No Intervention: Control
There will be no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nomophobia Scale
Time Frame: Pre-test
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
Pre-test
Smartphone Addiction Scale-Short Form
Time Frame: Pre-test
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
Pre-test
Nomophobia Scale
Time Frame: 6 weeks after pre-test
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
6 weeks after pre-test
Smartphone Addiction Scale-Short Form
Time Frame: 6 weeks after pre-test
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
6 weeks after pre-test
Nomophobia Scale
Time Frame: Follow-up (18 weeks after pre-test)
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
Follow-up (18 weeks after pre-test)
Smartphone Addiction Scale-Short Form
Time Frame: Follow-up (18 weeks after pre-test)
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
Follow-up (18 weeks after pre-test)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2024

Primary Completion (Actual)

March 30, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

October 9, 2024

First Submitted That Met QC Criteria

October 21, 2024

First Posted (Actual)

October 24, 2024

Study Record Updates

Last Update Posted (Actual)

July 14, 2025

Last Update Submitted That Met QC Criteria

July 9, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smartphone Addiction

Clinical Trials on Motivational Interview

Subscribe